The WHO international drug monitoring programme
- 1 January 2003
- book chapter
- Published by Elsevier
- Vol. 26, 548-557
- https://doi.org/10.1016/s0378-6080(03)80057-0
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Data-mining analyses of pharmacovigilance signals in relation to relevant comparison drugsEuropean Journal of Clinical Pharmacology, 2002
- Bayesian neural networks with confidence estimations applied to data miningComputational Statistics & Data Analysis, 2000
- A Retrospective Evaluation of a Data Mining Approach to Aid Finding New Adverse Drug Reaction Signals in the WHO International DatabaseDrug Safety, 2000
- From association to alert—a revised approach to international signal analysisPharmacoepidemiology and Drug Safety, 1999
- A Bayesian neural network method for adverse drug reaction signal generationEuropean Journal of Clinical Pharmacology, 1998
- The Role of the WHO Programme on International Drug Monitoring in Coordinating Worldwide Drug Safety EffortsDrug Safety, 1998
- Risks of non-sedating antihistaminesThe Lancet, 1997
- How Does Cystitis Affect a Comparative Risk Profile of Tiaprofenic Acid with Other Non-Steroidal Antiinflammatory Drugs? An International Study Based on Spontaneous Reports and Drug Usage DataBasic & Clinical Pharmacology & Toxicology, 1997
- Omeprazole and visual disorders: seeing alternativesPharmacoepidemiology and Drug Safety, 1996
- New Pharmacovigilance Information on an Old DrugClinical Drug Investigation, 1994